This suppressive effect represents a mechanism of “immune evasion” by the tumor, as dysfunctional NK cells are characterized by the downregulation of the main activating receptors involved in tumor recognition (NCRs, DNAM‐1, and NKG2D) and their presence is associated with an adverse clinical outcome [130]. This evidence concerns the gene CD226 and neoplasm.